Author:
Rehrl Jakob,Karttunen Anssi-Pekka,Nicolaï Niels,Hörmann Theresa,Horn Martin,Korhonen Ossi,Nopens Ingmar,De Beer Thomas,Khinast Johannes G.
Reference27 articles.
1. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT);Aksu;Eur. J. Pharm. Sci.,2012
2. An integrated approach for dynamic flowsheet modeling and sensitivity analysis of a continuous tablet manufacturing process;Boukouvala;Comput. Chem. Eng.,2012
3. Chatterjee, S., 2012. FDA Perspective on Continuous Manufacturing [WWW Document]. IFPAC Annu. Meet. URL (accessed 21.03.16).
4. Using residence time distributions (RTDs) to address the traceability of raw materials in continuous pharmaceutical manufacturing;Engisch;J. Pharm. Innov.,2016
5. FDA, U.S.D. of H. and H.S., 2004. Guidance for Industry - PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献